Showing Results for
- Academic Journals (14)
Search Results
- 14
Academic Journals
- 14
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedIn the Special Report by Alfredo Tartarone, Giuseppina Gallucci, Chiara Lazzari, Rosa Lerose, Lucia Lombardi & Michele Aieta, titled 'Crizotinib-induced cardiotoxicity: the importance of a proactive monitoring and...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): Glen W Barrisford aff1 , Evgeniy I Kreydin aff1 , Mark A Preston aff1 , Dayron Rodriguez aff1 , Mukesh G Harisighani aff2 , Adam S Feldman [*] aff1 KEYWORDS diagnostic imaging; testicular neoplasms;...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedPeripheral T-cell lymphomas are aggressive lymphomas with poor outcomes for which novel treatments are urgently needed. Alisertib (MLN8237) is a second-generation oral Aurora A kinase inhibitor. Treatment with alisertib...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): Harry Raftopoulos [*] aff1 aff2 , Ralph Boccia aff3 , William Cooper aff4 , Erin O'Boyle aff5 , Richard J Gralla aff6 KEYWORDS APF530; cancer; chemotherapy-induced nausea and vomiting; extended-release;...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): Roberto Petrioli [*] aff1 , Giandomenico Roviello aff1 , Anna Ida Fiaschi aff2 , Letizia Laera aff1 , Salvatora Tindara Miano aff1 , Daniele Marrelli aff3 , Franco Roviello aff4 , Vincenzo Bianco aff5 ,...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): Diego Marquez-Medina aff1 , Sanjay Popat [*] aff2 KEYWORDS adenocarcinoma; afatinib; EGF receptor; ErbB2; ErbB4; irreversible; non-small-cell lung cancer; second generation; squamous; tyrosine kinase...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): Claire Thom [*] KEYWORDS acute myeloid leukemia; AML; ASP2215; Astellas; European Hematology Association Congress; FLT3 mutation Q How did you come to be in the role you are in today as Vice...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): Jehan Dupuis [*] aff1 KEYWORDS anti-CD20; chronic lymphocytic leukemia; infusion-related reactions; minimal residual disease; obinutuzumab The introduction of the anti-CD20 monoclonal antibody...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): Boju Pan aff1 , Quan Liao [*] aff1 , Zheyu Niu aff1 , Li Zhou aff1 , Yupei Zhao aff1 KEYWORDS CAFs; chemotherapy; CXCL12; pancreatic ductal adenocarcinoma; SPARC Pancreatic ductal adenocarcinoma...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): Bruno Daniele [*] aff1 , Adina Croitoru aff2 , Christos Papandreou aff3 , Jean-Pierre Bronowicki aff4 , Philippe Mathurin aff5 , Fatima Serejo aff6 , Per Stål aff7 , Juan Turnes aff8 , Vlad Ratziu aff9 ,...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): Sebastian Szmit [*] aff1 KEYWORDS cardio-oncology; dasatinib; pleural effusion; pulmonary hypertension; sildenafil Basic clinical aspects Pulmonary arterial hypertension (PAH) seems to be a rare...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): Marta Maleszewska aff1 , Bozena Kaminska [*] aff1 KEYWORDS epi-drugs; gliomas; histone modifications; histone-modifying enzyme inhibitors; transcription regulation The state of chromatin and...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): Bekir Hacioglu aff1 , Serkan Akin aff1 , Ali R Sever aff2 , Kadri Altundag [*] aff1 KEYWORDS adjuvant; breast cancer; chemotherapy; complete remission; HER2-positive; intratumoral heterogeneity; locally...
-
From:Future Oncology (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): Alok Mishra [*] aff1 aff2 , Bhudev C Das [**] aff1 aff2 aff3 KEYWORDS AP-1; cervical cancer; curcumin; HPV; NF-κB; oral cancers More than four decades ago, the link between human papillomavirus...